Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 13, 2025

SELL
$123.8 - $132.96 $522,683 - $561,357
-4,222 Closed
0 $0
Q4 2023

Feb 13, 2025

SELL
$100.18 - $109.02 $151,271 - $164,620
-1,510 Reduced 26.34%
4,222 $460 Million
Q3 2023

Feb 13, 2025

SELL
$102.95 - $114.33 $70,211 - $77,973
-682 Reduced 10.63%
5,732 $590 Million
Q2 2023

Feb 13, 2025

BUY
$108.61 - $118.38 $126,747 - $138,149
1,167 Added 22.24%
6,414 $740 Million
Q1 2023

Feb 13, 2025

SELL
$102.94 - $114.86 $209,379 - $233,625
-2,034 Reduced 27.94%
5,247 $647 Million
Q4 2022

Feb 13, 2025

SELL
$87.44 - $112.11 $250,428 - $321,083
-2,864 Reduced 28.23%
7,281 $808 Million
Q3 2022

Feb 13, 2025

SELL
$84.53 - $94.96 $1.11 Million - $1.25 Million
-13,127 Reduced 56.41%
10,145 $874 Million
Q2 2022

Feb 13, 2025

SELL
$83.49 - $94.64 $80,317 - $91,043
-962 Reduced 3.97%
23,272 $2.12 Billion
Q1 2022

Feb 13, 2025

BUY
$73.51 - $82.4 $88,506 - $99,209
1,204 Added 5.23%
24,234 $1.99 Billion
Q4 2021

Feb 13, 2025

BUY
$72.28 - $90.54 $413,152 - $517,526
5,716 Added 33.01%
23,030 $1.77 Billion
Q3 2021

Feb 13, 2025

BUY
$71.68 - $78.83 $1 Million - $1.1 Million
13,995 Added 421.66%
17,314 $1.3 Billion
Q2 2021

Feb 13, 2025

BUY
$70.31 - $77.77 $233,358 - $258,118
3,319 New
3,319 $258 Million
Q1 2021

Feb 13, 2025

SELL
$68.86 - $81.11 $184,475 - $217,293
-2,679 Closed
0 $0
Q4 2020

Feb 13, 2025

BUY
$71.77 - $79.65 $215 - $238
3 Added 0.11%
2,679 $219 Million
Q3 2020

Feb 13, 2025

SELL
$73.18 - $82.95 $48,298 - $54,747
-660 Reduced 19.78%
2,676 $222 Million
Q2 2020

Feb 13, 2025

BUY
$70.42 - $80.13 $4,225 - $4,807
60 Added 1.83%
3,336 $258 Million
Q3 2019

Feb 13, 2025

SELL
$76.08 - $82.93 $87,492 - $95,369
-1,150 Reduced 25.98%
3,276 $276 Million
Q2 2019

Feb 13, 2025

BUY
$69.84 - $81.59 $268,185 - $313,305
3,840 Added 655.29%
4,426 $371 Million
Q1 2019

Feb 13, 2025

BUY
$69.58 - $79.36 $40,773 - $46,504
586 New
586 $274 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $227B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ategra Capital Management, LLC Portfolio

Follow Ategra Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ategra Capital Management, LLC with notifications on news.